PETER GARCIA: Open Payments
NPI 1437273687 · SANTA MARIA,, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 10 payments from 7 companies in 2025. Trend: 2023 $247 · 2024 $143 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $60 |
| ABBVIE INC. | 2 | $44 |
| Almatica Pharma LLC | 2 | $37 |
| Janssen Pharmaceuticals, Inc | 1 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| TMS NeuroHealth Centers Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
Products named: ARISTADA, VRAYLAR, LOREEV XR, INVEGA SUSTENNA, FANAPT, TMS NeuroHealth Centers Inc., CAPLYTA.
Industry payments across CA — which companies pay providers there.
